Literature DB >> 23152547

Comparative evaluation of the Nanosphere Verigene RV+ assay and the Simplexa Flu A/B & RSV kit for detection of influenza and respiratory syncytial viruses.

Kevin Alby1, Elena B Popowitch, Melissa B Miller.   

Abstract

Using retrospective (n = 200) and prospective (n = 150) nasopharyngeal specimens, we evaluated the Nanosphere Verigene RV+ and the Focus Diagnostics Simplexa Flu A/B & RSV tests. Overall, RV+ demonstrated sensitivities and specificities of 96.6% and 100% for influenza A virus, 100% and 99.7% for influenza B virus, and 100% and 100% for respiratory syncytial virus (RSV), while the Simplexa test sensitivities and specificities were 82.8 and 99.7%, 76.2 and 100%, and 94.6 and 100%, respectively.

Entities:  

Mesh：

Year:  2012        PMID： 23152547      PMCID： PMC3536264          DOI： 10.1128/JCM.02504-12

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  5 in total

1.  Performance of a rapid antigen test (Binax NOW® RSV) for diagnosis of respiratory syncytial virus compared with real-time polymerase chain reaction in a pediatric population.

Authors:  Karen Miernyk; Lisa Bulkow; Carolynn DeByle; Lori Chikoyak; Kimberlee Boyd Hummel; Thomas Hennessy; Rosalyn Singleton
Journal:  J Clin Virol       Date:  2010-12-15       Impact factor: 3.168

2.  Retrospective and prospective verification of the Cepheid Xpert influenza virus assay.

Authors:  Elena B Popowitch; Elaine Rogers; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2011-07-20       Impact factor: 5.948

3.  Real-time detection of influenza a, influenza B, and respiratory syncytial virus a and B in respiratory specimens by use of nanoparticle probes.

Authors:  Paul J Jannetto; Blake W Buchan; Kimberly A Vaughan; Joellen S Ledford; Dennis K Anderson; Donald C Henley; Neil B Quigley; Nathan A Ledeboer
Journal:  J Clin Microbiol       Date:  2010-09-08       Impact factor: 5.948

4.  Clinical performance of the 3M Rapid Detection Flu A+B Test compared to R-Mix culture, DFA and BinaxNOW Influenza A&B Test.

Authors:  Christine C Ginocchio; Madhavi Lotlikar; Leon Falk; Suman Arora; Margaret Kowerska; Mark Bornfreund; Ryhana Manji
Journal:  J Clin Virol       Date:  2009-05-05       Impact factor: 3.168

5.  Applicability of a real-time quantitative PCR assay for diagnosis of respiratory syncytial virus infection in immunocompromised adults.

Authors:  L J R van Elden; A M van Loon; A van der Beek; K A W Hendriksen; A I M Hoepelman; M G J van Kraaij; P Schipper; M Nijhuis
Journal:  J Clin Microbiol       Date:  2003-09       Impact factor: 5.948
  5 in total
  24 in total

1.  Comparison of Simplexa Flu A/B & RSV PCR with cytospin-immunofluorescence and laboratory-developed TaqMan PCR in predominantly adult hospitalized patients.

Authors:  Marie L Landry; David Ferguson
Journal:  J Clin Microbiol       Date:  2014-05-21       Impact factor: 5.948

2.  Evaluation of Simplexa Flu A/B & RSV for direct detection of influenza viruses (A and B) and respiratory syncytial virus in patient clinical samples.

Authors:  Musa Hindiyeh; Liat Kolet; Tal Meningher; Merav Weil; Ella Mendelson; Michal Mandelboim
Journal:  J Clin Microbiol       Date:  2013-05-08       Impact factor: 5.948

3.  Performance Characteristics of Xpert Flu/RSV XC Assay.

Authors:  Elena B Popowitch; Melissa B Miller
Journal:  J Clin Microbiol       Date:  2015-05-27       Impact factor: 5.948

Review 4.  Emerging technologies for the clinical microbiology laboratory.

Authors:  Blake W Buchan; Nathan A Ledeboer
Journal:  Clin Microbiol Rev       Date:  2014-10       Impact factor: 26.132

5.  Development and optimization of a real-time PCR assay for detection of herpes simplex and varicella-zoster viruses in skin and mucosal lesions by use of the BD Max open system.

Authors:  Ana María Cárdenas; Paul H Edelstein; Kevin Alby
Journal:  J Clin Microbiol       Date:  2014-10-01       Impact factor: 5.948

6.  Clinical utility of a near patient care microarray based diagnostic test for influenza and respiratory syncytial virus infections.

Authors:  Xiu-Hong Chen; Ji-Hua Wang; Xiao-Hong Yao
Journal:  Int J Clin Exp Med       Date:  2015-09-15

7.  Comparison of the FilmArray RP, Verigene RV+, and Prodesse ProFLU+/FAST+ multiplex platforms for detection of influenza viruses in clinical samples from the 2011-2012 influenza season in Belgium.

Authors:  Liesbeth Van Wesenbeeck; Hanne Meeuws; Andrea Van Immerseel; Gabriela Ispas; Kristiane Schmidt; Lieselot Houspie; Marc Van Ranst; Lieven Stuyver
Journal:  J Clin Microbiol       Date:  2013-07-03       Impact factor: 5.948

8.  Comparison of the Simplexa FluA/B & RSV direct assay and laboratory-developed real-time PCR assays for detection of respiratory virus.

Authors:  Mitchell W Woodberry; Rohit Shankar; Anne Cent; Keith R Jerome; Jane Kuypers
Journal:  J Clin Microbiol       Date:  2013-09-18       Impact factor: 5.948

9.  Comparison of NxTAG Respiratory Pathogen Panel and Anyplex II RV16 Tests for Multiplex Detection of Respiratory Pathogens in Hospitalized Children.

Authors:  Pedro Brotons; Desiree Henares; Irene Latorre; Antonio Cepillo; Cristian Launes; Carmen Muñoz-Almagro
Journal:  J Clin Microbiol       Date:  2016-09-14       Impact factor: 5.948

10.  Clinical Performance of the AllplexTM Respiratory Panel 1 Test Compared to SimplexaTM Flu A/B and RSV for Detection of Influenza Virus and Respiratory Syncytial Virus Infection Including Their Subtyping.

Authors:  Jeeyong Kim; Jeonghun Nam; Woongsik Jang; Chae Seung Lim
Journal:  Med Princ Pract       Date:  2019-03-04       Impact factor: 1.927
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.